amaZon speed Ion Trap
1 - 5 of 145
October 19, 2020

Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award

• HUPO 2020 Science and Technology Award for Commercialization of TIMS Technology • True Single Cell 1,000 Protein Group Results from Mann Lab leverage dia-PASEF® and further improvements in ultra-low flow Evosep chromatography and modified TIMS/PASEF set-up • Significant Improvements in Quantitative Targeted 4D-Proteomics with prm-PASEF® • Licensing of PhoX cross-linker from Heck Lab enables caps-PASEF structural proteomics

September 30, 2020

Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies

BILLERICA, Massachusetts, September 30, 2020 -- Bruker Corporation (Nasdaq: BRKR) announces the recent acquisition of the Integrated Proteomics Pipeline (IP2) search engine and proteomics workflow software platform. IP2 was developed by Integrated Proteomics Applications Inc, a company founded by leading proteomics researcher Professor John Yates III, together with Drs. Robin Park and Tao Xu. Financial details of the transaction were not disclosed.

September 29, 2020

Bruker Daltonics Newsletter - September 2020

In this issue: Keeping employees safe while supporting customers during the Covid-19 pandemic, MS Imaging-Guided Microproteomics for Spatial Omics on a single instrument, SpatialOMx® combines molecular imaging and 4D-Omics to probe tissue substructures, Uncover proteomic profiles in tumor subpopulations, Capture greater molecular insight into the complex tissue environment, Guide for writing successful proposals for SpatialOMx® and timsTOF flex, John R. Yates, III and Robin Park from the Scripps Research Institute, High-througput 4D-Proteomics™, Proteomic Interrogation of Primary Insulin-secreting Pancreatic β-cells, CCS values to enable 4-dimensional annotation of metabolic features, 4 Reasons to switch to 4D-Proteomics™ on the timsTOF Platform.

July 27, 2020

Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe

Bruker Corporation today announced the launch of the FluoroType® SARS-CoV-2 plus next-generation 6-plex PCR assay for the highly specific detection of the SARS-CoV-2 virus